UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes

Haematologica (Roma), 2013-04, Vol.98 (4), p.568-575

2013

Volltextzugriff (PDF)

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

Leukemia, 2017-11, Vol.31 (11), p.2538-2539

2017

Volltextzugriff (PDF)

Choosing the Appropriate Denominator for Counting BM Blasts

Leukemia research, 2017-04, Vol.55, p.S4-S4

2017

Volltextzugriff (PDF)

The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma

Annals of oncology, 2006-10, Vol.17 (10), p.1539-1545

2006

Volltextzugriff (PDF)

Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival

Clinical epigenetics, 2021-01, Vol.13 (1), p.9-9, Article 9

2021

Volltextzugriff (PDF)

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Leukemia, 2011-01, Vol.25 (1), p.110-120

2011

Volltextzugriff (PDF)

The Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts can be Improved by Considering Bone Marrow Blasts from Nonerythroid Cells

Leukemia research, 2017-04, Vol.55, p.S135-S136

2017

Volltextzugriff (PDF)

Calculating IPSS-R by Enumerating Bone Marrow Blasts from Nonerythroid Cellularity Improves Outcome Prediction in MDS with Erythroid Predominance

Leukemia research, 2017-04, Vol.55, p.S137-S138

2017

Volltextzugriff (PDF)

Prognostic Implication of the Percentage of Erythroid Cells in Bone Marrow at Diagnosis in Patients with Myelodysplastic Syndrome

Leukemia research, 2017-04, Vol.55, p.S151-S152

2017

Volltextzugriff (PDF)

144 CSF3R POINT MUTATIONS IN A COHORT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND NEUTROPENIA AT DIAGNOSIS

Leukemia research, 2015-04, Vol.39, p.S73-S73

2015

Volltextzugriff (PDF)

261 ERYTHROLEUKEMIA APPEARS TO BE A CONTINUUM OF MDS WITH ERYTHROID HYPERPLASIA AND SHARES OUTCOME AND CYTOGENETIC FEATURES WITH RAEB-1 WITH ≥50% ERYTHROPOIESIS

Leukemia research, 2015-04, Vol.39, p.S131-S132

2015

Volltextzugriff (PDF)

260 CONSIDERING PERCENTAGE OF BLASTS ON THE BASIS OF NON-ERYTHROID COMPARTMENT MIGHT IMPROVE THE CLASSIFICATION AND PROGNOSTICATION OF MDS WITH EXCESS OF BLAST CELLS

Leukemia research, 2015-04, Vol.39, p.S130-S131

2015

Volltextzugriff (PDF)

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Haematologica (Roma), 2013-10, Vol.98 (10), p.1554-1562

2013

Volltextzugriff (PDF)

271 ACQUISITION OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH IPSS LOW AND INTERMEDIATE-1 RISK. STUDY FROM THE SPANISH GROUP OF MYELODYSPLASTIC SYNDROME

Leukemia research, 2015-04, Vol.39, p.S136-S136

2015

Volltextzugriff (PDF)

Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia

Leukemia, 2008-07, Vol.22 (7), p.1368-1376

2008

Volltextzugriff (PDF)

Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status

International journal of hematology, 2008-11, Vol.88 (4), p.387-395

2008

Volltextzugriff (PDF)

P-069 Contribution of SNP-arrays and mutational studies to diagnosis and prognosis of CMML with low-risk cytogenetic features or no metaphases

Leukemia research, 2013-05, Vol.37, p.S53-S54

2013

Volltextzugriff (PDF)

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy

Haematologica (Roma), 2011-07, Vol.96 (7), p.996-1001

2011

Volltextzugriff (PDF)

P-068 Trisomy 8 in de novo MDS, constitutional or not constitutional?

Leukemia research, 2013-05, Vol.37, p.S53-S53

2013

Volltextzugriff (PDF)

122 SNP-A karyotyping in MDS and MDS/MPN cases with normal karyotype

Leukemia research, 2011, Vol.35, p.S47-S47

2011

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: SEX DETERMINES DIFFERENTIAL GENOMIC PROFILES IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) INVOLVING UNDERREPRESENTATION OF SRSF2 GENE MUTATION

Leukemia research, 2023-05, Vol.128, p.107188, Article 107188

2023

Volltextzugriff (PDF)

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: IMPACT OF GERIATRIC ASSESSMENT AND SOMATIC MUTATIONS IN HIGH-RISK MYELODYSPLASTIC SYNDROMES NOT ELIGIBLE FOR ALO-HCST. CET-AZA-2016–1 2022 UPDATE. ON BEHALF OF THE CETLAM GROUP

Leukemia research, 2023-05, Vol.128, p.107221, Article 107221

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: CLINICAL AND MOLECULAR CHARACTERIZATION OF PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS

Leukemia research, 2023-05, Vol.128, p.107176, Article 107176

2023

Volltextzugriff (PDF)

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: GENOMIC DETERMINANTS OF DYSMYELOPOIESIS AND EVALUATION OF ITS PROGNOSTIC IMPACT IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

Leukemia research, 2023-05, Vol.128, p.107231, Article 107231

2023

Volltextzugriff (PDF)

315 Prognostic impact of performance status and comorbidity on the overall survival of patients with myelodysplastic syndromes: A prospective evaluation

Leukemia research, 2011, Vol.35, p.S126-S126

2011

Volltextzugriff (PDF)

1 – 25 von 268

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(258)
Mit Volltextzugriff
(240)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

Choosing the Appropriate Denominator for Counting BM Blasts

The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma

Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

The Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts can be Improved by Considering Bone Marrow Blasts from Nonerythroid Cells

Calculating IPSS-R by Enumerating Bone Marrow Blasts from Nonerythroid Cellularity Improves Outcome Prediction in MDS with Erythroid Predominance

Prognostic Implication of the Percentage of Erythroid Cells in Bone Marrow at Diagnosis in Patients with Myelodysplastic Syndrome

144 CSF3R POINT MUTATIONS IN A COHORT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND NEUTROPENIA AT DIAGNOSIS

261 ERYTHROLEUKEMIA APPEARS TO BE A CONTINUUM OF MDS WITH ERYTHROID HYPERPLASIA AND SHARES OUTCOME AND CYTOGENETIC FEATURES WITH RAEB-1 WITH ≥50% ERYTHROPOIESIS

260 CONSIDERING PERCENTAGE OF BLASTS ON THE BASIS OF NON-ERYTHROID COMPARTMENT MIGHT IMPROVE THE CLASSIFICATION AND PROGNOSTICATION OF MDS WITH EXCESS OF BLAST CELLS

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

271 ACQUISITION OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH IPSS LOW AND INTERMEDIATE-1 RISK. STUDY FROM THE SPANISH GROUP OF MYELODYSPLASTIC SYNDROME

Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia

Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status

P-069 Contribution of SNP-arrays and mutational studies to diagnosis and prognosis of CMML with low-risk cytogenetic features or no metaphases

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy

P-068 Trisomy 8 in de novo MDS, constitutional or not constitutional?

122 SNP-A karyotyping in MDS and MDS/MPN cases with normal karyotype

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: SEX DETERMINES DIFFERENTIAL GENOMIC PROFILES IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) INVOLVING UNDERREPRESENTATION OF SRSF2 GENE MUTATION

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: IMPACT OF GERIATRIC ASSESSMENT AND SOMATIC MUTATIONS IN HIGH-RISK MYELODYSPLASTIC SYNDROMES NOT ELIGIBLE FOR ALO-HCST. CET-AZA-2016–1 2022 UPDATE. ON BEHALF OF THE CETLAM GROUP

Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: CLINICAL AND MOLECULAR CHARACTERIZATION OF PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: GENOMIC DETERMINANTS OF DYSMYELOPOIESIS AND EVALUATION OF ITS PROGNOSTIC IMPACT IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

315 Prognostic impact of performance status and comorbidity on the overall survival of patients with myelodysplastic syndromes: A prospective evaluation

Suchergebnisse filtern